You are here

  • Home
  • Archive
  • Volume 70, Issue 9
  • Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Chatzidionysiou K, Lie E, Nasonov E, et al
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
Annals of the Rheumatic Diseases 2011;70:1575-1580.